Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
---|---|---|---|---|
121805 | L-778123 hydrochloride | 253863-00-2 | 98% | |
L-778123 hydrochloride is an inhibitor of FPTase and GGPTase-I with IC50 of 2 nM and | ||||
2073106 | Lerociclib HCl (G1T38 HCl) | 2097938-59-3 | ≧98.0% | |
Lerociclib HCl (G1T38)is a novel, selective,differentiated oral CDK4/6 inhibitor with | ||||
S510902 | Cenicriviroc ( TAK-652 ) | 497223-25-3 | 98% Min. | |
Cenicriviroc ( TAK-652, TBR-652) is an experimental drug candidate for the treatment | ||||
1711222 | Asciminib ( ABL001 ) | 1492952-76-7 | 99.35% | |
Asciminib, Bulk in stock, contact us by email for the quotation. Kg scale intermediat | ||||
18381 | JPH203 HCl ( Nanvuranlat ) | 1597402-27-1 | ≧95.0% | |
JPH203, also known as KYT-0353, is a potent and selective LAT1 selective ( L-type ami | ||||
18435 | Ritlecitinib ( PF-06651600 ) | 1792180-81-4 | ≧98.0% | |
Ritlecitinib ( PF-06651600 ) is a potent and selective JAK3 inhibitor. PF-06651600, a | ||||
184321 | Ensartinib ( X396 ) | 1370651-20-9 | >98% | |
Ensartinib is an orally available small molecule inhibitor of the receptor tyrosine k | ||||
512194 | Lazertinib | 1903008-80-9 | 98% Min. | |
Description:Lazertinib is a an orally available third-generation, selective inhibi | ||||
185235 | Trilaciclib (G1T28) | 1374743-00-6 | >98% | |
TRILACICLIB (G1T28), A HIGHLY POTENT, TRANSIENT CDK 4/6 INHIBITOR WITHIC50s OF 1 nM A | ||||
18722 | Fezolinetant | 1629229-37-3 | >98% | |
Fezolinetant, also known as ESN-364, is Neurokinin-3 (NK-3) receptor antagonist which | ||||
187122 | Gefapixant | 1015787-98-0 | 98% | |
Gefapixant, also known as AF-219 or MK-7264, is a P2X3 receptor antagonist. Gefapixan | ||||
188281 | Arimoclomol maleate | 289893-26-1 | 98% | |
Arimoclomol, also known as BRX-220, is potentially useful for the treatment of Nieman |
Overnight Delivery
Fast & Safe Delivery Worldwide
Safety and Security
Intimate Service
Copyright 2015-2022 武汉永璨生物科技有限公司 版权所有 | 鄂ICP备17005301号-1